Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect a recognition of the relevance of the research, with comments like 'This doesn't seem surprising' and references to categorizing subtypes based on symptoms, which demonstrate an understanding of the article's focus. The tone is generally supportive and acknowledges the potential for improved communication and treatment, indicating a moderate but meaningful engagement with the findings.
Most discussions agree with the study's premise that categorizing lupus based on clinical features and patient-reported outcomes is valuable, as shown by phrases like 'doesn't seem surprising' and references to new approaches.
The posts demonstrate moderate interest, especially by highlighting potential improvements in understanding and treating lupus, but they do not delve deep into specifics, indicating a general curiosity.
Posts show some engagement through sharing opinions and acknowledging the significance of the research, but lack detailed critique or extensive discussion, suggesting a surface-level engagement.
Participants seem to recognize the study’s importance in advancing lupus research and patient care, hinting at a moderate impact on clinical perspectives or future research directions.
This doesn't seem surprising to me! How about a new approach to lupus: Type 1 symptoms (inflammation) and Type 2 (chronic pain, fatigue, brain fog). The Type 2 drive people into trials, but the study drugs target pathways for Type 1 disease. https://t.co/CtKTSCsp4k https://t.co/ZqbKIXfcCM
Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to categorize lupus subtypes https://t.co/PBV1lpo96G https://t.co/x8YsofYUXW
RT @drbags71: This doesn't seem surprising to me! How about a new approach to lupus: Type 1 symptoms (inflammation) and Type 2 (chronic p…
RT @ACR_Journals: Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to…
RT @ACR_Journals: Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to…
RT @ACR_Journals: Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to…
At the ACR 2021 annual congress, approximately 112 abstracts highlighted patient-reported outcomes across various rheumatic diseases, emphasizing assessment tools, quality of life, and disease perception.
RT @drbags71: This doesn't seem surprising to me! How about a new approach to lupus: Type 1 symptoms (inflammation) and Type 2 (chronic p…
This doesn't seem surprising to me! How about a new approach to lupus: Type 1 symptoms (inflammation) and Type 2 (chronic pain, fatigue, brain fog). The Type 2 drive people into trials, but the study drugs target pathways for Type 1 disease. https://t.co/CtKTSCsp4k https://t.co/ZqbKIXfcCM
RT @ACR_Journals: Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to…
RT @ACR_Journals: Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to…
RT @ACR_Journals: Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to…
Just accepted in Arthritis Care & Research: Utilizing clinical characteristics and patient‐reported outcome measures to categorize lupus subtypes https://t.co/PBV1lpo96G https://t.co/x8YsofYUXW